联合治疗公司

US · UTHR #836 按市值排名上市于 1970

533.12 -8.39 -1.55%

实时 - 追踪5344个代码 - 心跳于446秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了3家。
机构持股总比例下降了0.9个百分点。

机构持股

机构持股比例: 99.27% -0.89pp
机构数量: 1,050 -3
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund67.27%

Hedge Fund20.37%

Public Company3.25%

Government Pension Fund3.01%

Private Company2.24%

Individual/Insider1.95%

Sovereign Wealth Fund1.67%

VC/PE Fund0.60%

Insurance Company0.33%

主要股东截至 2026-06-30

BlackRock 12.34% · 5.29M 股

Avoro Capital Advisors LLC 6.48% · 2.78M 股

Vanguard Capital Management, LLC 5.10% · 2.19M 股

Vanguard Portfolio Management, LLC 4.48% · 1.92M 股

State Street Global Advisors 4.43% · 1.90M 股

Renaissance Technologies Corp. 3.98% · 1.71M 股

Wellington Management Group 3.22% · 1.38M 股

Geode Capital Management, LLC 2.32% · 996.60K 股

Janus Henderson Group plc 1.94% · 831.13K 股

Norges Bank Investment Management 1.62% · 694.75K 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 0次买入 · 50次卖出

姓名	职务	持股比例
Martine Rothblatt	Chairperson & CEO	1.56%
Paul Mahon	General Counsel	0.11%
Thomas Thompson	Independent Director	0.05%
Richard Giltner	Independent Director	0.05%
Michael Benkowitz	President	0.05%
James Edgemond	Chief Financial Officer	0.04%
Raymond Kurzweil	Independent Director	0.03%
Nilda Mesa	Independent Director	0.01%
Judy Olian	Independent Director	0.01%
Louis Sullivan	Independent Director & Member of the Scientific Advisory Board	0.01%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-10-01	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–574.23
2026-09-30	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–584.66
2026-09-30	Paul Mahon	General Counsel	Derivative Exercise and Sale	-8,300	$146.03–573.15
2026-09-28	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–486.77
2026-09-27	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–486.01
2026-09-24	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–478.95
2026-09-23	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–480.33
2026-09-22	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–500.05
2026-09-21	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–499.07
2026-09-20	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–496.62
2026-09-17	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–498.25
2026-09-16	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–501.60
2026-09-16	Paul Mahon	General Counsel	Derivative Exercise and Sale	-8,300	$146.03–501.58
2026-09-15	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–505.20
2026-09-14	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–504.57
2026-09-13	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–506.48
2026-09-13	Nilda Mesa	Independent Director	Open Market Disposition	-98	$505.98
2026-09-13	Nilda Mesa	Independent Director	Derivative Exercise and Sale	-130	$110.86–505.79
2026-09-10	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–508.21
2026-09-09	Martine Rothblatt	Chairperson & CEO	Derivative Exercise and Sale	-9,500	$117.76–508.80

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。